aod9604 clinical trial weight loss results kg or percent Once-weekly cagrilintide for management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 AOD-9604 – Research Peptide Variant:20mg serum
Pay in 4 interest-free payments of $7.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30